2 years. Before the expiration of the validity period, eligible enterprises can reapply.

2024-01-29

According to the "Guizhou Province Integrity Demonstration Enterprise Joint Incentive Policy (Trial)", during the validity period, Longli County will actively provide joint incentive policies for four listed enterprises, including bank credit, credit guarantees, financial interest subsidies, industrial support, government procurement, project support, cost reduction, and other aspects. At the same time, Longli County will include the four listed enterprises in the county's integrity "red list", establish a demonstration enterprise credit file system, and implement dynamic management of relevant industry credit information databases.

complies with the Good Manufacturing Practice of Drugs (revised in 2010) and is now publicly announced

2024-01-29

complies with the Good Manufacturing Practice of Drugs (revised in 2010) and is now publicly announced. The public notice period is 10 working days, from December 10, 2019 to December 23, 2019. Catalogue of Drug GMP Certification Review and Publicity of Guizhou Provincial Food and Drug Evaluation and Inspection Center (No. 163) Acceptance number Enterprise Name certification scope On site inspection time inspector GZ20190027 Guizhou Liangji Pharmaceutical Co., Ltd Hard capsule, granule, granule (A), mixture, syrup, spray, ointment (including Chinese medicine extract) November 14th to November 16th, 2019 Zhang Yuanrong, Yang Xin, Zhang Yunjie

At the same time, Longli County will include the four listed enterprises in the county's integrity "red list"

2024-01-29

According to the "Guizhou Province Integrity Demonstration Enterprise Joint Incentive Policy (Trial)", during the validity period, Longli County will actively provide joint incentive policies for four listed enterprises, including bank credit, credit guarantees, financial interest subsidies, industrial support, government procurement, project support, cost reduction, and other aspects. At the same time, Longli County will include the four listed enterprises in the county's integrity "red list", establish a demonstration enterprise credit file system, and implement dynamic management of relevant industry credit information databases.

Catalogue of Drug GMP Certification Review and Publicity of Guizhou Provincial Food and Drug Evaluation and Inspection Center (No. 163)

2024-01-29

after on-site inspection and audit, Guizhou Liangji Pharmaceutical Co., Ltd. complies with the Good Manufacturing Practice of Drugs (revised in 2010) and is now publicly announced. The public notice period is 10 working days, from December 10, 2019 to December 23, 2019. According to the website of the Guizhou Provincial Drug Administration, on December 10, 2019, the Guizhou Provincial Food and Drug Evaluation and Inspection Center issued a Drug GMP Certification Review Notice (No. 163) According to the Measures for the Administration of Good Manufacturing Practice Certification of Drugs and the Notice on Issuing the Measures for the Administration of Good Manufacturing Practice Certification of Drugs (State Food and Drug Administration [2011] No. 365) issued by the State Food and Drug Administration, Catalogue of Drug GMP Certification Review and Publicity of Guizhou Provincial Food and Drug Evaluation and Inspection Center (No. 163)